These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32830995)

  • 1. Re: Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-AnalysisA. Pilatz, K. Dimitropoulos, R. Veeratterapillay, Y. Yuan, M. I. Omar, S. MacLennan, T. Cai, F. Bruyère, R. Bartoletti, B. Köves, F. Wagenlehner, G. Bonkat and B. Pradere
    Jazayeri SB; Balaji KC
    J Urol; 2020 Dec; 204(6):1349-1350. PubMed ID: 32830995
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply from Authors re: Riccardo Bartoletti, Tommaso Cai. Prostate Biopsies Should Be Performed According to a Standard of Care. Eur Urol 2013;63:528-9.
    Wagenlehner F; van Oostrum E; Tenke P; Tandogdu Z; Cek M; Grabe M; Wullt B; Pickard R; Naber KG; Pilatz A; Weidner W; Bjerklund-Johansen TE
    Eur Urol; 2013 Mar; 63(3):529-30. PubMed ID: 22868669
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis.
    Pilatz A; Dimitropoulos K; Veeratterapillay R; Yuan Y; Omar MI; MacLennan S; Cai T; Bruyère F; Bartoletti R; Köves B; Wagenlehner F; Bonkat G; Pradere B
    J Urol; 2020 Aug; 204(2):224-230. PubMed ID: 32105195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study: L. C. Macleod, W. J. Ellis, L. F. Newcomb, Y. Zheng, J. D. Brooks, P. R. Carroll, M. E. Gleave, R. S. Lance, P. S. Nelson, I. M. Thompson, Jr., A. A. Wagner, J. T. Wei and D. W. Lin J Urol 2017;197:1026-1033.
    Denize J; Nouhaud FX; Cornu JN; Pfister C
    J Urol; 2017 Sep; 198(3):709-711. PubMed ID: 28579000
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: The Impact of Nocturia on Mortality: A Systematic Review and Meta-AnalysisJ. S. Pesonen, R. Cartwright, R. W. M. Vernooij, Y. Aoki, A. Agarwal, A. Mangera, A. D. Markland, J. F. Tsui, H. Santti, T. L. Griebling, A. E. Pryalukhin, J. Riikonen, R. M. Tähtinen, C. P. Vaughan, T. M. Johnson, II, A. Auvinen, D. Heels-Ansdell, G. H. Guyatt and K. A. O. Tikkinen
    Montorsi F; Capogrosso P
    J Urol; 2020 Sep; 204(3):589-590. PubMed ID: 32364835
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis: M. A. Liss, W. Kim, D. Moskowitz and R. J. Szabo J Urol 2015;194:397-402.
    Wagenlehner F
    J Urol; 2016 Jan; 195(1):224-5. PubMed ID: 26432938
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J. Feliciano, E. Teper, M. Ferrandino, R. J. Macchia, W. Blank, I. Grunberger and I. Colon J Urol 2008; 179: 952-955.
    Ng CF; Chan SY
    J Urol; 2008 Oct; 180(4):1570-1; author reply 1571. PubMed ID: 18718610
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Factors predicting prostatic biopsy Gleason sum under grading: D. A. Stackhouse, L. Sun, F. R. Schroeck, J. Jayachandran, A. A. Caire, C. O. Acholo, C. N. Robertson, D. M. Albala, T. J. Polascik, C. F. Donatucci, K. E. Maloney and J. W. Moul J Urol 2009; 182: 118-124.
    Labanaris AP; Kühn R; Zugor V
    J Urol; 2010 Jan; 183(1):396-7; author reply 397-8. PubMed ID: 19945124
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial Comments on Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis.
    Samarinas M
    J Urol; 2020 Sep; 204(3):414. PubMed ID: 32762317
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial Comments on Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis.
    Rizzo M; Liguori G; Trombetta C
    J Urol; 2020 Sep; 204(3):414-415. PubMed ID: 32762313
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate: O. Kehinde, M. Al-Maghrebi, M. Sheikh and J. T. Anim J Urol 2013; 189: 911–915.
    Ozgur BC; Sarici H; Doluoglu OG; Telli O; Eroglu M
    J Urol; 2014 Mar; 191(3):871-3. PubMed ID: 24360872
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate: E. O. Kehinde, M. Al-maghrebi, M. Sheikh and J. T. Anim J Urol 2013, 189: 911-915.
    Gaylis F; Fink L
    J Urol; 2013 Oct; 190(4):1443-4. PubMed ID: 23623974
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: antibiotic prophylaxis for shock wave lithotripsy in patients with sterile urine before treatment may be unnecessary: a systematic review and meta-analysis: Y. Lu, F. Tianyong, H. Ping, L. Liangren, Y. Haichao and W. Qiang J Urol 2012;188:441-448.
    Mosli HA; Aaronson DS; Forouzeh Z; Paul L
    J Urol; 2013 Feb; 189(2):775-7. PubMed ID: 22986034
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance-How Many Cores are Enough?: K. N. Pham, C. R. Porter, K. Odem-Davis, E. M. Wolff, C. Jeldres, J. T. Wei and T. M. Morgan J Urol 2015;194:674-679.
    Zhou Z; Yan W; Ji Z
    J Urol; 2016 May; 195(5):1624-1625. PubMed ID: 26876586
    [No Abstract]   [Full Text] [Related]  

  • 15. Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary?
    Puig J; Darnell A; Bermúdez P; Malet A; Serrate G; Baré M; Prats J
    Eur Radiol; 2006 Apr; 16(4):939-43. PubMed ID: 16391904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The eternal enigma in prostatic biopsy access route.
    Fabiani A; Principi E; Filosa A; Servi L
    Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Efficacy and Safety of Prostatic Arterial Embolization: Systematic Review with Meta-Analysis and Meta-Regression: S. R. Shim, K. J. Kanhai, Y. M. Ko and J. H. Kim J Urol 2017;197:465-479.
    Narayan V; Jung JH; Dahm P
    J Urol; 2017 Jul; 198(1):215-216. PubMed ID: 28365370
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review.
    Cussans A; Somani BK; Basarab A; Dudderidge TJ
    BJU Int; 2016 May; 117(5):725-31. PubMed ID: 26709240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy.
    Papagiannopoulos D; Abern M; Wilson N; O'Block N; Raff L; Coogan C; Latchamsetty KC
    J Urol; 2018 Jan; 199(1):155-160. PubMed ID: 28807644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.